1988•New England Journal of MedicineRequires access

Mosaicism for an Intragenic Deletion in a Boy with Mild Ornithine Transcarbamylase Deficiency

Anne Maddalena, Donna M. Sosnoski, Gerard T. Berry, Robert Luke Nussbaum

Open publisher page 69 citations

Abstract

ORNITHINE TRANSCARBAMYLASE (OTC) is the X-linked enzyme that catalyzes the condensation of carbamyl phosphate and ornithine, forming citrulline in the urea cycle. Its activity in the mitochondria of liver cells is essential for the detoxification of ammonia, and its complete absence is usually lethal in the neonatal period.1 The majority of cases of nontransient neonatal hyperammonemia are due to inborn deficiencies of this enzyme. A milder form of OTC deficiency has a later onset and is characterized by episodes of hyperammonemia caused by infection or excessive protein intake. Even when protein intake is limited, male patients with partial OTC deficiency . . .

About this research paper

What this paper is about

ORNITHINE TRANSCARBAMYLASE (OTC) is the X-linked enzyme that catalyzes the condensation of carbamyl phosphate and ornithine, forming citrulline in the urea cycle. Its activity in the mitochondria of liver cells is essential for the detoxification of ammonia, and its complete absence is usually lethal in the neonatal period.1 The majority of cases of nontransient neonatal hyperammonemia are due to inborn deficiencies of this enzyme. A milder form of OTC deficiency has a later onset and is characterized by episodes of hyperammonemia caused by infection or excessive protein intake. Even when protein intake is limited, male patients with partial OTC deficiency . . .

Why it matters

OpenAlex reports 69 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

ORNITHINE TRANSCARBAMYLASE (OTC) is the X-linked enzyme that catalyzes the condensation of carbamyl phosphate and ornithine, forming citrulline in the urea cycle. Its activity in the mitochondria of liver cells is essential for the detoxification of ammonia, and its complete absence is usually lethal in the neonatal period.1 The majority of cases of nontransient neonatal hyperammonemia are due to inborn deficiencies of this enzyme. A milder form of OTC deficiency has a later onset and is characterized by episodes of hyperammonemia caused by infection or excessive protein intake. Even when protein intake is limited, male patients with partial OTC deficiency . . .

Key concepts: Urea cycle, Hyperammonemia, Ornithine transcarbamylase, Carbamyl Phosphate, Ornithine transcarbamylase deficiency, Ornithine Carbamoyltransferase, Citrulline, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Mosaicism for an Intragenic Deletion in a Boy with Mild Ornithine Transcarbamylase Deficiency — Research Paper | ScholarLens